Finerenone is a selective, nonsteroidal mineralocorticoid receptor antagonist that is used in the therapy of chronic renal disease in patients with type 2 diabetes to slow progression of renal dysfunction and reduce the risk of cardiovascular disease morbidity and mortality.

Finerenone, marketed under the brand name Kerendia among others, is a medication used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. [8] .

ChemSpider record containing structure, synonyms, properties, vendors and database links for finerenone, 1050477-31-0, BTBHLEZXCOBLCY-QGZVFWFLSA-N

2022年4月6日 · Finerenone blocks the mineralocorticoid receptor to reduce mortality and morbidity in patients with chronic severe congestive heart failure with an ejection fraction. 14 It is distributed relatively equally between the heart and the kidney. Finerenone structure

2D Structure. An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor.

2021年10月14日 · Finerenone-D5 | C21H22N4O3 | CID 169440416 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.

Finerenone UNII DE2O63YV8R Molecular formula C 21 H 22 N 4 O 3 Molecular weight 378.43 Percent composition C 66.65% H 5.86% N 14.81% O 12.68% Standard InChI InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1 Standard InChIKey …